Andrea Ferreira-Gonzalez, PhD

Professor, Pathology 
Director, Molecular Diagnostics Lab 
Division of Molecular Diagnostics
Department of Pathology 
Virginia Commonwealth University 
1994 - Present 
Office: 804-828-9564
aferreir@vcu.edu

 

Education | VCU/MCV Appointments | VCU Service | Professional Service | 
Editorial Advisory Boards
 | Recent Invited Presentations | Recent Publications

Education

Graduate Education

PhD, Microbiology/Immunology
Graduate School of Arts and Science 
George Washington University
Washington, DC
1994 

 

MS, Clinical Biochemistry
School of General Chemistry 
National University of Cordoba
Cordoba, Argentina
1985

Virginia Commonwealth University and Medical Center Appointments

Chair, Division Molecular Diagnostics
Professor of Pathology 
Director Molecular Diagnostics Lab

Virginia Commonwealth University Service 

VCU Promotion and Tenure Policy Review Committee 2011-present
VCU School of Medicine, Faculty Grievance Committee, alternate 2010-present
Department of Pathology, Executive Committee, 2009-present
Department of Pathology, Pathology Improvement Committee, 2004-present
Department of Pathology, Clinical Practice Strategic Planning Committee, 2002-present
VCU Internal Review Board, 2000-present 

Back to top

Professional Service

Clinical Laboratory Improvement Advisory Committee (CLIAC).  Member  advisory committee to Secretary of HHS.

 

Professional Relations Committee.  Member.  Association for Molecular Pathology, 2004-present

 

Professional Relations Committee, Chair. Association for Molecular Pathology, 2001-present

 

Secretary’s Advisory Committee on Genetics, Health and Society Genetic Testing Oversight Task Force.  Chair, Advisory Committee to Secretary of HHS, 2007-10

 

Secretary’s Advisory Committee on Genetics, Health and Society.  Member,  advisory committee to Secretary of HHS, 2006-09       

             

Personalized Healthcare Workgroup.  Member, advisory committee to Secretary of HHS, 2006-09

 

President.  Association for Molecular Pathology, 2007

 

Nominating Committee,  Chair. American Association for Clinical Chemistry, 2006-07

 

Annual Meeting Organizing Committee 2006, American Association for Clinical Chemistry.  Member, 2005-06       

 

Molecular and Clinical Genetics Devices Panel of the Medical Devices Advisory Committee, Center for Devices and Radiological Health, FDA.  Member, 2004-07

 

Molecular Pathology Division, Treasurer.  American Association for Clinical Chemistry, 2004-05

 

Molecular and Clinical Genetics Devices Panel of the Medical Devices Advisory Committee, Center for Devices and Radiological Health, FDA.  Consultant, 2002-05

 

Subcommittee in Sequencing Methods (MM-9).  National Committee for Clinical Laboratory Standards (NCCLS).  Member, 2002-05

 

Nominating Committee. Molecular Diagnostics Subdivision. American Association for Clinical Chemistry, 2003

Back to top

Editorial Advisory Boards

Journal Molecular Diagnostics. Timothy O’Leary Ed in Chief,  2007-present
Journal Clinical Laboratory Analysis. R. McPherson, Ed in Chief, 1998-present

Recent Invited Presentations

Molecular Diagnostics - Workshop on Principles and Practices.  International Federation of Clinical Chemistry, Guatemala City, Guatemala, November 16-21, 2012

 

Navigating the future of Molecular Diagnostics. Annual Association for Molecular Pathology, Los Angeles, California, October 2012

 

Laboratory-Developed Tests in the genomic medicine era: validation, regulation and challenges face by new technologies and clinical applications. ADAPT 2012, Washington DC, September 19, 2012

 

Sequencing Methods in Diagnostic Laboratory Medicine. IV Annual Next Generation Diagnostics Summit. Washington DC August 21-22, 2012

 

Laboratory-Developed Tests in the genomic medicine era: validation, regulation and challenges face by new technologies and clinical applications. Biomarker world Congress. Philadelphia May 2012

 

Next Generation Sequencing in Clinical Practice.  Annual Meeting American Association of Clinical Chemistry, Los Angeles July 2012

 

Laboratory-Developed Tests in the genomic medicine era: validation, regulation and challenges face by new technologies and clinical applications. Massachusetts General Hospital, Harvard Medical School, Department of Pathology Grand Rounds.  Boston, MA May 23, 2012

 

Laboratory-Developed Tests in the genomic medicine era: validation, regulation and challenges face by new technologies and clinical applications. Biomarker world Congress. Philadelphia May 2012

 

Molecular Diagnostics- Workshop on Principles and Practices.  International Federation of Clinical Chemistry, Guatemala City, Guatemala, December 12-18, 2011

 

Molecular Diagnostics for the Practicing Physician.  Bon Secours Health System Continuing Education, Richmond VA November 2011

 

Regulatory Update.  Annual Meeting Association for Molecular Pathology. Dallas, TX November 2011

 

Next Generation Pathogens for Immunocompromised Patient. Third Annual Next Generation Diagnostics Summit. Cambridge Health Institute.  Washington DC, August 2011

 

Clinical Studies and Validation of Molecular Diagnostics. Third Annual Next Generation Diagnostics Summit. Cambridge Health Institute.  Washington DC, August 2011

 

Introduction to Sanger Sequencing in Clinical Practice.  Third Annual Next Generation Diagnostics Summit. Cambridge Health Institute.  Washington DC, August 2011

 

Update in Molecular Diagnostics.  Annual Meeting of Association of Pathology Chairs, Monterrey CA July 2011

 

Next Generation Sequencing in Clinical Practice.  Annual Meeting American Association of Clinical Chemistry, Atlanta GA July 2011

 

Basics of Nucleic Acid Technology. Annual Meeting American Association for Clinical Chemistry, Atlanta GA, July 2011

 

FDA’s History of Oversight of Laboratory Developed Tests. 27th Clinical Virology Symposium, Daytona Beach, FL May 2011

 

Case Study: Molecular Diagnostics at VCU. Molecular Diagnostics 2011 Spring Conference G2 Intelligence, Boston MA April 13-15, 2011

 

Next Generation Sequencing in Clinical Practice and Public Health Practices.  Annual meeting, College of medical Genetics, March 15 2011, Vancouver Canada

 

Navigating the Future of Personalized Medicine.  Duchema Meeting, Frankfurt, Germany February 3 2011

Back to top

Recent Publications

Schrijver IAziz NFarkas DHFurtado MGonzalez AFGreiner TCGrody WWHambuch TKalman LKant JAKlein RDLeonard DGLubin IMMao ,Nagan NPratt VMSobel MEVoelkerding KVGibson JS  Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. J Mol Diagn. 2012 Nov;14(6):525-40. doi: 10.1016/j.jmoldx.2012.04.006. Epub 2012 Aug 20.

 

Rahmani M, Aust MM, Attkisson E, Williams DC Jr, Ferreira-Gonzalez A, Grant S. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism. Cancer Res. 2012 Dec 12. [Epub ahead of print] PMID: 23243017   

 

Rahmani M, Aust MM, Attkisson E, Williams DC Jr, Ferreira-Gonzalez A, Grant S. Inhibition of Bcl-2 antiapoptotic members by obatoclax potently enhances sorafenib-induced apoptosis in human myeloid leukemia cells through a Bim-dependent process. Blood. 2012 Jun 21;119(25):6089-98. Epub 2012 Mar 23. PMID: 22446485 [PubMed - in process]

 

Juusola JS, Anderson P, Sabato F, Wilkinson DS, Pandya A, Ferreira-Gonzalez A Performance Evaluation of Two Methods Using Commercially Available Reagents for PCR-Based Detection of FMR1 Mutation..J Mol Diagn. 2012 Jul 2. [Epub ahead of print] PMID: 22765921.  

 

Jones KH, York TP, Juusola J, Ferreira-Gonzalez A, Maes HH, Jackson-Cook C. Genetic and environmental influences on spontaneous micronuclei frequencies in children and adults: a twin study. Mutagenesis. 2011 Nov;26(6):745-52. Epub 2011 Jul 15.

 

Favorable Toor AA, Sabo RT, Chung HM, Roberts C, Manjili RH, Song S, Williams DC Jr, Edmiston W, Gatesman ML, Edwards RW, Ferreira-Gonzalez A, Clark WB, Neale MC, McCarty JM, Manjili MH. Outcomes in Patients with High Donor-Derived T Cell Count after in Vivo T Cell-Depleted Reduced-Intensity Allogeneic Stem Cell Transplantation.  .  Biol Blood Marrow Transplant. 2011 Oct 17. [Epub ahead of print]  

 

Sandhu B, Vitazka P, Ferreira-Gonzalez A, Pandya A, Vachhani R, Bouhaidar D, Zfass A, Sanyal A. Presence of SPINK-1 variant alters the course of chronic pancreatitis. J Gastroenterol Hepatol. 2011 Jun;26(6):965-9. doi: 10.1111/j.1440-1746.2011.06713.x. PMID: 21375584 [PubMed - in process]

 

The Association for Molecular Pathology's approach to supporting a global agenda to embrace personalized genomic medicine. AMP Whole Genome Analysis Working Group.  J Mol Diagn. 2011 May;13(3):249-51.

 

Caliendo AM, Valsamakis A, Bremer JW, Ferreira-Gonzalez A, Granger S, Sabatini L, Tsongalis GJ, Wang YF, Yen-Lieberman B, Young S, Lurain NS.Multi-Laboratory Evaluation of Real-Time PCR Tests for Hepatitis B Virus DNA Quantification. J Clin Microbiol. 2011 Aug; 49(8):2854-8. [Epub ahead of print Jun 22]